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Abstract
A 90-year-old woman developed a severe stroke (National Institutes of Health Stroke Scale Score (NIHSS) 24) due to an
occlusion of the left carotid T. Computed tomography 60 min after symptom onset showed a large area of tissue at risk
with a relatively large area of reduced cerebral blood volume indicating a relative large infarct core. After successful
reperfusion, she recovered very well with only residual facial asymmetry (NIHSS 1). Up to now, therapeutic decisions for
intravenous thrombolysis and endovascular treatment were mainly based on these time windows, although it was well
known that the individual time window may vary widely due to a large variability of the quality of collateral circulation. The
recently presented results of the DAWN trial have demonstrated that patients can be successfully treated in a time
window up to 24 h when selected by imaging and clinical criteria. The described case impressively demonstrates that this
positive selection of patients beyond established treatment time windows does not implicate in reverse that patient
selection for therapy within the established time windows can be based on the same imaging criteria. In conclusion, patient
selection beyond the established time windows may be based on the available techniques, but imaging-based decisions
against therapy in patients within the established time windows should be made only with extreme caution.
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Case report
A 90-year-old woman living at an old people’s home sud-
denly developed a severe right-sided hemiparesis and dif-
ficulty to speak. She was immediately transferred to the
emergency department of the University Hospital of Bern
and examined by the neurologist on duty 50 min after
symptom onset. The patient was hemodynamically stable
with a blood pressure of 185/55 mmHg at admission. Clini-
cally she presented with the National Institutes of Health
Stroke Scale Score (NIHSS) of 24/42 with a severe paresis
on her right side, global aphasia, a hemispatial neglect, and
sensory deficits.
Naive computed tomography (CT) 60 min after symptom
onset excluded any bleeding or early infarct signs (Figure 1).
CT angiography demonstrated a left carotid T occlusion with
occlusion of the distal internal carotid artery and the prox-
imal segments of the middle and anterior cerebral artery
(Figure 2). Time to maximum (Tmax)perfusion imagingmaps
showed a large area of severe hypoperfusion mainly within
the territory of the middle cerebral artery (Figure 1). A larger
proportion of the hypoperfused brain tissue showed reduced
cerebral blood volume (CBV) indices as indicated on the
CBV maps (Figure 1). The interdisciplinary stroke team
decided to perform a direct mechanical endovascular treat-
ment (EVT), because the patient was treated with
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Rivaroxaban for atrial fibrillation and factor Xa activity was
184 ng/ml (specific factor Xa activity for Rivaroxaban).
Reperfusion was then delayed due to an iatrogenic dissection
of the femoral artery and could finally be successfully
achieved only 191 min after symptom onset (Thrombolysis
in cerebral infarction (TICI) 3 reperfusion) with a Solitaire
Stent Retriever (Medtronic, USA). The patient was trans-
ferred to the stroke unit and clinical examination on the
following day revealed only a residual slight facial asymme-
try (NIHSS 1/42). A control CT 40 h after reperfusion
showed only very small areas of infarction (Figure 3). She
developed a hemodynamically stable non-ST-segment ele-
vation myocardial infarction during the first 24 h which was
treated conservatively. After 3 days, she could be transferred
to a geriatric rehabilitation unit in a good general condition.
Discussion
Reperfusion therapy by intravenous thrombolysis (IVT)
and EVT is highly effective and only 5–14 patients had
to be treated with IVT and 3–7 patients with EVT in the
large randomized trials to prevent one patient from death or
dependency.1–9 Therapeutic success relies on the already
established infarct core and the size and localization of the
salvageable penumbral tissue. Because the size of the
penumbra continuously declines with the elapsed time,
the therapeutic effect is highly time-dependent and treat-
ment time windows of 4.5 h for IVT and 7.3 h for EVT have
been defined by pooled analysis of the patients treated in
the large trials.10,11 Up to now, therapeutic decisions for
IVT and EVT were mainly based on these time windows,
although it was well known that the individual time
Figure 1. Tmax CT perfusion maps showing a large area of severe hypoperfusion mainly within the territory of the middle cerebral
artery. A greater proportion of the hypoperfused brain tissue showed reduced CBV indices as indicated on the CBV maps. CBV:
cerebral blood volume; CT: computed tomography; Tmax: time to maximum.
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window may vary widely due to a large variability of the
quality of collateral circulation. The recently published
results of the DAWN trial have demonstrated that patients
can be successfully treated in a time window up to 24 h
when selected by imaging and clinical criteria.12 The
DAWN trial included patients with large artery occlusion
between 6 h and 24 h after symptom onset for EVT, if
patients presented with a so-called clinical-image mis-
match: Patients had to be clinically severely affected
(NIHSS  10) but infarct core had to be restricted (<21
cc if patients were 80 years, <31 cc if patients were <80
years, and NIHSS 10 or <51 cc if patients were <80 years
and NIHSS  20). The trial revealed a clear effect of
reperfusion therapy in these selected patients: The number
needed to treat was reported to be 2.8 for 90-day functional
independency. The results of this trial will probably lead to
a paradigm change in therapeutic decisions in acute stroke
treatment. Future patient selection will be based more and
more on imaging criteria. The imaging-based selection of
patients beyond the established treatment time windows
may offer a treatment option for patients which had been
excluded from therapy so far.
Our above-described case impressively demonstrates
that this positive selection of patients beyond established
treatment time windows does not implicate in reverse that
patient selection for therapy within the established time
windows can be based on the same imaging criteria.
The decision for therapy in our patient was on the clin-
ical evaluation, the time window, and native CT not show-
ing any infarct signs. CT perfusion showed already large
Figure 3. Control CT 40 h after reperfusion therapy showing only small hypodense areas of infarction. CT: computed tomography.
Figure 2. Axial non-enhanced CT at admission (a) showing hyperdense artery sign (red arrow) of the left distal ICA. On the axial
maximum intensity projection CT angiography (b) the distal ICA, the middle cerebral artery, as well as the lateral part of the A1 segment
of the anterior cerebral artery are not opacified, representing carotid T occlusion (dotted circle), which is also demonstrated in the
anterior view of the volume rendered 3-D CT angiography (c). In this early arterial phase, the left side ICA proximal to the occlusion
site is less opacified than the right side. There is a reduced opacification of the left posterior cerebral artery (blue arrow) as it is supplied
by the anterior circulation (fetal origin of the posterior cerebral artery (PCA)). There is also a retrograde filling of the medial part of the
A1 segment anterior cerebral artery (ACA) via Acom. CT: computed tomography; ICA: internal carotid artery.
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areas of reduced CBV within the hypoperfused tissue
(Figure 1). Because areas of reduced CBV approximate the
infarct core, one may have decided against reperfusion
therapy in this elderly patient. The rapid clinical recovery
after reperfusion and the small areas of infarction on
follow-up imaging demonstrate the possible inaccuracy of
the imaging-based approximation of the penumbra.
The problem still to be resolved for an optimized
patient selection is the accurate imaging of the core and
penumbra: Although positron emission tomography
(PET) imaging was able to accurately visualize the infarct
core and the hypoperfused tissue, it is not practicable in
the acute setting of stroke.13 Magnetic resonance (MR)
and CT allow the approximation of the penumbra but
show a relevant inaccuracy of the imaging techniques
used up to now.14–16 The core is estimated using MR by
the lesion in diffusion-weighted imaging (DWI) and the
hypoperfused area by perfusion imaging. With CT, the
core is visualized by CBV and the hypoperfused area by
perfusion imaging. Visualization of the infarct core by
MR imaging is more accurate than by CT, but diffusion
lesion reversal can occur because the DWI lesion may
overestimate the infarct core and contain up to 25% false
positive, that is, surviving tissue.17 More accurate is the
definition of the core by quantitative analysis of the cal-
culated apparent diffusion coefficient maps.17 Imagina-
tion of the hypoperfused tissue at risk by MR and CT
perfusion imaging relies on surrogates of perfusion para-
meters calculated from nondeconvolved (e.g. time to
peak) or deconvolved (e.g. CBF, mean transit time, and
Tmax) tissue residue function (time contrast curve) of the
intravascular contrast bolus.15 Different maps computed
from MR and CT imaging have been developed and com-
pared to PET measurements. Recent studies indicate that
Tmax thresholds of >6 s improve the prediction of salvage-
able tissue compared to previous maps.18 Nevertheless,
estimation of the tissue at risk based on maps derived from
simple thresholding is prone to errors in about 25% of the
patients with variations of the predicted penumbra of up to
100 ml.19 Newer studies applying machine learning tech-
niques instead of only using somehow arbitrary thresholds
of surrogate parameters have shown first promising
results with improved accuracy of the penumbra ima-
ging.20 Nevertheless, the accuracy of the CT or MR
imaging-based visualization of the infarct core and
penumbra still has to be improved for an optimized patient
selection. Until then, patient selection beyond the estab-
lished time windows may be based on the available tech-
niques, but imaging-based decisions against therapy in
patients within the established time windows should be
made only with extreme caution.
In addition, this case shows though patients aged 90 years
or older despite being at risk for a poorer clinical outcome
compared to younger patients may still benefit from EVT
especially if they had a good pre-stroke functional status.
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